medigraphic.com
SPANISH

Medicina Crítica

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • Policies
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2013, Number 3

<< Back Next >>

Med Crit 2013; 27 (3)

Toxic shock syndrome: clinical and diagnostic

Esteban CME, Floristan VVJM, Olagorta GS, Belloc SJ, García IJJ
Full text How to cite this article

Language: Spanish
References: 10
Page: 183-186
PDF size: 132.81 Kb.


Key words:

Toxic shock syndrome, bacterial toxin, Staphylococcus aureus bacteria.

ABSTRACT

We present the clinical case of a patient with a final diagnosis of toxic shock syndrome. The toxic shock syndrome is a rare but fatal disease caused by a bacterial toxin. In most cases is caused by a toxin derived from certain types of staphylococcal bacteria (Staphylococcus aureus). Sometimes, it can be derived from Staphylococcus pyogenes. Clinically it may progress rapidly with high rates of mortality. Therefore, being a rare condition, it is necessary to have early diagnosis and immediate treatment. We emphasize the exceptional nature of the case, its appearance in a short period of time and fulminant course.


REFERENCES

  1. Ferguson AJ. Gram-positive toxic shock syndromes. Lancet Infect Dis. 2009;9(5):281-290.

  2. Holt P. Tampon-associated toxic shock syndrome. BMJ. 1980;281:1321-1322.

  3. Yok-Ai Que PM. Staphylococcus aureus (including staphylococcal toxic shock). In: Mandell GL, Bennett JE, Dolin R, et al. Principles and practice of infectious diseases. Seventh ed. Philadelphia, Pa: Elseiver Churchill Livingstone; 2009. chap 195.

  4. Balk RA. Severa and septic shock: definitions, epidemiology and clinical manifestations. Crit Care Clin. 2000;16:179-192.

  5. Kain KC, Schulzer M, Chow AW. Clinical spectrum of nonmenstrual toxic shock syndrome (TSS): comparison with menstrual TSS with multivariate discriminant analyses. Clin Infect Dis. 1993;16:100-106.

  6. Emerging Infections. Microbial threats to health in the United States. Washington, DC: National Academy, 1992.

  7. Fuente: Organización Panamericana de la Salud. División de vacunas e inmunización. Vacunación segura: cómo enfrentar los eventos supuestamente atribuidos a la vacunación o inmunización. Washington, DC: OPS; 2002:2009.

  8. Blanco AC, Moreno M, Orsi M, Albano L. Shock toxico no menstrual por Staphylococcus aureus. Archivos Argentinos de Pediatría. 2005;103(5):426-429.

  9. Toxic shock syndrome. Mayo Clinic website. Availabe at: http://www.mayoclinic.com/health/ toxic-shock-syndrome/DS00221. Update May 2009. Accesed July 6, 2009.

  10. Darenberg J, Soderquist B, Henriques Normark B, Norrby-Teglund A. Differences in potency of intravenous polyespecific inmunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome. CID. 2004;38:836-842.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Crit. 2013;27